Marc Beer is the co-founder and chairman of Renovia Inc. and a businessman. This company which is based in Boston manufactures products that deal with pressing medical issues.
Currently, Renovia is at the forefront of treating disorders that deal with the pelvic floor. These include issues like urinary incontinence. The medical startup’s deal closed a total of 42 million dollars. This includes a debt of 10 million dollars and a closing of 32 million dollars will ensure that their venture moves forward.
According to research, pelvic floor conditions, affect approximately 250 million in the world. The company will now be able to manufacture new products that deal with pelvic floor disorders. In addition to this, Renovia is also developing other products that deal with therapy and the diagnosis of the disorders. In April, the FDA approved Leva. This was the medical startup’s first product.
The funds that the medical firm received will be used to develop and test a new kind of Leva device. In addition to this, three other products that will be used for diagnosis and the therapy of the disorders will also be initiated. Renowned medical firms such as Ascension Ventures, Perceptive Advisors and Longwood Fund were present during the Series B raising of the funds.
Marc Beer who is also the CEO of Renovia was pleased that these companies had joined his company in the quest of trying to treat the sensitive pelvic floor conditions. He added that joining forces will assist them in coming up with a platform for digital health, which will also enlighten customers on emerging treatment options, information on understanding the disorders that deal with the pelvic floor and provide vital data. Consequently, the costs of health care will be lowered in the country.
Pelvic floor conditions include fistula which causes lack of bladder control. They may also cause fecal incontinence and the prolapsed of the pelvis. These conditions are brought about by many factors these include delayed childbirth, rape or sexual assault, accidents among many others.
About Marc Beer:
In August 2016, Marc Beer partnered with Yolanda Lorie, and Ramon Iglesias, MD and they started Renovia. Mr. Beer has worked in the pharmaceuticals, diagnostics, development and commercialization experience of biotechnology, and devices for over 25 years. Prior to founding, Renovia, Mr. Beer founded ViaCell. This company is a biotechnology firm which collects, preserves, and develops stem cells from the umbilical cord. He was also the CEO of the company. Learn more: https://www.linkedin.com/in/marcbeer
Mr. Beer attended Miami University in Ohio and attained a BS. He has worked extensively in the medical field where he has made immeasurable strides. He also belongs to various leading boards. These include Good Start Genetics, Minerva Neurosciences, Notre Dame Research, and Mass Life Science Board among others.